Abbonarsi

Outcomes of introducing shared decision-making for tracheostomy on prolonged intubated critical patients - 17/11/25

Doi : 10.1016/j.rmed.2025.108370 
Shu-Hung Kuo a, b, c, d , Chien-Wei Hsu a , Wei-Chun Huang a , Chun-Hao Yin e, f , Ying-Chun Li f , Tsung-Hsien Lin b, g, ⁎ , Yao-Shen Chen h , Jin-Shuen Chen h
a Department of Critical Medicine, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan 
b Graduate Institute of Clinical Medicine, Kaohsiung Medical University, Kaohsiung City, Taiwan 
c College of Medicine, School of Medicine, National Sun Yat-sen University, Kaohsiung City, Taiwan 
d School of Nursing, Fooyin University, Kaohsiung City, Taiwan 
e Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan 
f Department of Business Management, Institute of Health Care Management, National Sun Yat-Sen University, Kaohsiung City, Taiwan 
g Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung City, Taiwan 
h Department of Administration, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan 

⁎Corresponding author. No. 100, Tzyou 1st Road, Sanmin Dist., Kaohsiung City, Taiwan.No. 100Tzyou 1st RoadSanmin Dist.Kaohsiung CityTaiwan

Abstract

Aim

Tracheostomy has been relatively unpopular in Taiwan. Here, we investigate the impact of shared decision-making (SDM) for tracheostomy on critical patients undergoing prolonged intubation.

Methods

We retrospectively enrolled 1464 patients admitted to a tertiary medical centre intensive care unit (ICU) due to respiratory failure between April 2017 and April 2023. A 2-to-1 propensity-score with nearest-neighbour matching was used to balance covariates across SDM and non-SDM groups. Outcomes, including tracheostomy rate, intubation to tracheostomy time, mortality rate, ventilator weaning rate, ICU admission days, length of hospital stay, and 6-month post-discharge readmission rate were collected. Binary outcomes (Tracheostomy rate, in-hospital mortality, and 6-month readmission rate) were analysed using multivariable logistic regression, reported as odds ratios (ORs) with 95 % confidence intervals (CIs). Continuous outcomes (Intubation to Tr. T, ICU days, and length of stay) were assessed with generalized linear models, reported as regression coefficients (β) with 95 % CIs.

Results

We found that SDM introduction was associated with a higher tracheostomy (44.3 % vs. 30.9 %, p < 0.001) and lower in-hospital mortality rates (15.7 % vs. 26.5 %, p = 0.004), but failed to demonstrate significant impacts on the intubation-to-tracheostomy time (25.8 ± 16.8 vs. 28.8 ± 17.6 d, p = 0.05) and the rest of the clinical outcomes. Subgroup analysis showed SDM had the greatest benefit to those with prior respiratory, neuromuscular, and malignant diseases.

Conclusion

Introducing SDM for prospective tracheostomy recipients is associated with better clinical outcomes in critical patients undergoing prolonged intubation.

Il testo completo di questo articolo è disponibile in PDF.

Graphical abstract




Image 1

Il testo completo di questo articolo è disponibile in PDF.

Highlights

•
SDM increased tracheostomy rates (44.3 % vs. 30.9 %, p < 0.001).
•
SDM reduced in-hospital mortality (20.9 % vs. 39.1 %, p < 0.001).
•
No clear benefit on time to tracheostomy (25.8 vs. 28.8 d, p = 0.05).
•
Greatest gains seen in respiratory, neuromuscular, malignant disease subgroups
•
SDM aligns treatment with patient values, improves decision-making quality

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Shared decision-making, Tracheostomy, Mortality, Intensive care unit


Mappa


© 2025  Elsevier Ltd. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 249

Articolo 108370- novembre 2025 Ritorno al numero
Articolo precedente Articolo precedente
  • A bench study comparing the performance of a novel test lung with a conventional model
  • Kazuto Doi, Makoto Hayashi, Mayumi Doi, Masashi Ebisawa, Junichi Kadota
| Articolo seguente Articolo seguente
  • Assessment of the metabolome across the glucose tolerance spectrum in adults with cystic fibrosis hospitalized for pulmonary exacerbations
  • Chin-An Yang, Jonathon Batross, Lucia A. Gonzalez Ramirez, Joshua Chandler, Douglas Walker, ViLinh Tran, Dean P. Jones, Gabriel Olveira, Thomas R. Ziegler, Vin Tangpricha, Jessica A. Alvarez

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.